loadpatents
name:-0.027224063873291
name:-0.006242036819458
name:-0.00038790702819824
Cavalli; Vera Patent Filings

Cavalli; Vera

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cavalli; Vera.The latest application filed is for "use of a octreotide as a therapeutic agent".

Company Profile
0.6.54
  • Cavalli; Vera - Muzzano N/A CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use of a octreotide as a therapeutic agent
Grant 8,541,364 - Bevec , et al. September 24, 2
2013-09-24
Use of Gonadorelin as a therapeutic agent
Grant 8,349,805 - Bevec , et al. January 8, 2
2013-01-08
Use of the peptide RFMWMR as a therapeutic agent
Grant 8,338,380 - Bevec , et al. December 25, 2
2012-12-25
Use of somatostatin-14 as a therapeutic agent
Grant 8,211,856 - Bevec , et al. July 3, 2
2012-07-03
Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine
Grant 8,193,149 - Bevec , et al. June 5, 2
2012-06-05
Use Of A Octreotide As A Therapeutic Agent
App 20110065630 - Bevec; Dorian ;   et al.
2011-03-17
Use Of Beta-melanotropin As A Therapeutic Agent, Eg For The Treatment Of Aids Or Alzheimer
App 20100323950 - Bevec; Dorian ;   et al.
2010-12-23
Use Of Glp-1 As A Therapeutic Agent
App 20100311643 - Bevec; Dorian ;   et al.
2010-12-09
Use Of Insulin C-peptide, Alone Or In Combination With Glp-1, As A Therapeutic Agent
App 20100292132 - Bevec; Dorian ;   et al.
2010-11-18
Use Of A Peptide As A Therapeutic Agent
App 20100286028 - Bevec; Dorian ;   et al.
2010-11-11
Use Of A Peptide As A Therapeutic Agent
App 20100286029 - Bevec; Dorian ;   et al.
2010-11-11
Use Of Salusin Beta Alone Or In Combination With Octreotide As A Therapeutic Agent
App 20100273701 - Bevec; Dorian ;   et al.
2010-10-28
Use Of A Peptide As A Therapeutic Agent
App 20100273700 - Bevec; Dorian ;   et al.
2010-10-28
Use Of A Peptide As A Therapeutic Agent
App 20100256043 - Bevec; Dorian ;   et al.
2010-10-07
Use Of Cnp-22, Alone Or In Combination With Physalemin, As A Therapeutic Agent
App 20100249017 - Bevec; Dorian ;   et al.
2010-09-30
Use Of A Peptide As A Therapeutic Agent
App 20100249019 - Bevec; Dorian ;   et al.
2010-09-30
Use Of A Peptide As A Therapeutic Agent
App 20100234306 - Bevec; Dorian ;   et al.
2010-09-16
Use Of The Peptide Pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys As A Therapeutic Agent
App 20100216722 - Bevec; Dorian ;   et al.
2010-08-26
Use Of Fibronectin Fragment (196-203 ) As A Therapeutic Agent
App 20100216724 - Bevec; Dorian ;   et al.
2010-08-26
Minigastrin As A Therapeutic Agent
App 20100210558 - Bevec; Dorian ;   et al.
2010-08-19
Therapeutic Uses Of Intermedin 47 And 53 Peptides
App 20100210538 - Bevec; Dorian ;   et al.
2010-08-19
Use Of Neuropeptide Sf, Alone Or In Combination With Glp-2, As A Therapeutic Agent
App 20100210532 - Bevec; Dorian ;   et al.
2010-08-19
Use Of Peptide Ll-37 As A Therapeutic Agent
App 20100210539 - Bevec; Dorian ;   et al.
2010-08-19
Use Of Leptin (22-56 ) As A Therapeutic Agent
App 20100210536 - Bevec; Dorian ;   et al.
2010-08-19
Use Of The Peptide Asn-asp-asp-cys-glu- Leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu Alone Or In Combination With The Peptide Thr-thr-ser-gln-val- Arg-pro-arg As A Therapeutic Agent
App 20100210553 - Bevec; Dorian ;   et al.
2010-08-19
Use Of Peptide As A Therapeutic Agent
App 20100210561 - Bevec; Dorian ;   et al.
2010-08-19
Use Of Neurotrophic Factor For Retinal Cholinergic Neurons (nfrcn) And Chorionic Gonadotropin-beta (109-145) As Therapeutic Agents
App 20100204108 - Bevec; Dorian ;   et al.
2010-08-12
Use Of Calcitonin As Anti-angiogenic Agent
App 20100204116 - Bevec; Dorian ;   et al.
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204090 - Bevec; Dorian ;   et al.
2010-08-12
Gamma 1 Msh Alone Or In Combination With Pentagastrin As A Therapeutic Agent
App 20100204143 - Bevec; Dorian ;   et al.
2010-08-12
Use Of Octreotide As A Therapeutic Agent
App 20100204149 - Bevec; Dorian ;   et al.
2010-08-12
Use Of A Peptide As A Therapeutic Agent
App 20100204129 - Bevec; Dorian ;   et al.
2010-08-12
Use Of Gluten Exorphin C : As A Therapeutic Agent
App 20100204152 - Bevec; Dorian ;   et al.
2010-08-12
Use Of Tyr-w-mif-1 And Urocortin 2 As Therapeutic Agents
App 20100204112 - Bevec; Dorian ;   et al.
2010-08-12
Therapeutic Use Of Peptide Yglf And Combination With Kvlpvpq
App 20100197605 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Peptide As A Therapeutic Agent
App 20100197599 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Secretin And Optionally Urodilatin As Therapeutic Agents
App 20100197586 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Peptide As A Therapeutic Agent
App 20100197587 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Somatostatin-14 As A Therapeutic Agent
App 20100197572 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Fibrinogen Receptor Antagonist And/or Follicular Gonadotropin Releasing Peptide As A Therapeutic Agent In The Treatment Of Streptococcus Pneumonia Infection
App 20100197601 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Rgdspasskp And Optionally Angiotensin Ii As Therapeutic Agents In The Treatment Of Eg S. Pneumoniae Infections
App 20100197603 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Peptide As A Therapeutic Agent
App 20100197604 - Bevec; Dorian ;   et al.
2010-08-05
Use Of Melanotrophin-potentiating Factor As A Therapeutic Agent
App 20100197608 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Peptide As A Therapeutic Agent
App 20100197588 - Bevec; Dorian ;   et al.
2010-08-05
Use Of The Peptide His-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe Alone Or In Combination With The Peptide Pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh As A Therapeutic Agent
App 20100197600 - Bevec; Dorian ;   et al.
2010-08-05
Use Of A Rgd-peptide And/or Parathyroid Hormone (1-34) As Anti-hiv Agent
App 20100197585 - Bevec; Dorian ;   et al.
2010-08-05
Substance P And Thyrotropin Releasing Hormone For Therapeutic Applications
App 20100190722 - Bevec; Dorian ;   et al.
2010-07-29
Use Of The Peptide Thymosin Beta 4 Alone Or In Combination With Cecropin A As A Therapeutic Agent
App 20100190713 - Bevec; Dorian ;   et al.
2010-07-29
Big Gastrin I As A Therapeutic Agent
App 20100190711 - Bevec; Dorian ;   et al.
2010-07-29
Use Of A Platelet Fibrinogen Receptor Hexapeptide Antagonist And Alpha-endorphin As Therapeutic Agents
App 20100190716 - Bevec; Dorian ;   et al.
2010-07-29
Use Of Peptide Yy, Alone Or In Combination With Glucagon-like Peptide, For Use In Medicine
App 20100190712 - Bevec; Dorian ;   et al.
2010-07-29
Use Of Melanin Concentrating Hormone And Met-enkephalin As Therapeutic Agents
App 20100190717 - Bevec; Dorian ;   et al.
2010-07-29
Use Of Melanocyte-stimulating Hormone Release-inhibiting Factor As A Therapeutic Agent In The Treatment Of Pseudomonas Aeruginosa Infection
App 20100190724 - Dorian; Bevec ;   et al.
2010-07-29
Use Of A Peptide As A Therapeutic Agent
App 20100184676 - Bevec; Dorian ;   et al.
2010-07-22
Use Of A Peptide As A Therapeutic Agent
App 20100184678 - Bevec; Dorian ;   et al.
2010-07-22
Use Of A Deslorelin And Mastoparan As A Therapeutic Agent
App 20100184698 - Bevec; Dorian ;   et al.
2010-07-22
Proadrenomedullin Alone Or In Combination With Big Gastrin I As A Therapeutic Agent
App 20100184674 - Bevec; Dorian ;   et al.
2010-07-22
Use Of Gly-pro-glu-oh (gpe) As A Therapeutic Agent
App 20100184708 - Bevec; Dorian ;   et al.
2010-07-22
Use Of The Human Pancreatic Polypeptide As A Therapeutic Agent
App 20100184677 - Bevec; Dorian ;   et al.
2010-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed